feed,title,long_url,short_url
Benzinga,"OKYO Pharma's Drug OK-101 Clears Customs in the US; To Be Used In Phase 2, First-In-Human, Clinical Trial For Patients With Dry Eye Disease",https://benzinga.com/general/biotech/23/03/31121248/okyo-pharmas-drug-ok-101-clears-customs-in-the-us-to-be-used-in-phase-2-first-in-human-clinical-t,https://da.gd/XrIuMn
